Clinical and Translational Science Pilot Program (CTSP)

The Clinical Translational Science Pilot Program (CTSP) is now accepting applications for the 2025 CTSI Translational Science Pilot Award, funded through the National Institutes of Health's (NIH) National Center for Advancing Translational Sciences (NCATS) Clinical and Translational Science Awards (CTSA) Program. The goal of the CTSI Translational Science Pilot Award is to fund highly meritorious research for the development of preliminary data to enable researchers to be competitive in applying for extramural funding that advances clinical and translational science.

This request for applications (RFA) is designed to stimulate and support transformative, innovative, interdisciplinary studies that seek to advance team science, implementation science, inter-institutional partnerships and/or community partnerships through understanding and addressing  the biological, behavioral, environmental, sociocultural and structural factors that influence women’s health across the lifespan. 

Successful translational science studies focus on a specific clinical and translational research area aimed to develop or test a translational science-directed hypothesis that addresses a barrier to progression of turning observations in the laboratory, clinic and community into interventions that improve the health of people more quickly. 

By applying one or more translational science principals, a translational science-directed hypothesis should generate a scientific, operational, financial or administrative innovation that addresses longstanding challenges along the translational research pipeline, transforming the way that research is done, making it faster, more efficient and more impactful.